Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy

Clinical trial NCT02002884 · COMPLETED

Trial details

NCT number: NCT02002884
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Palsy Spasticity

Start date: 2014-03-28
Primary completion: 2017-07-04
Enrollment: 351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.